There are four clinically relevant molecular subtypes of invasive ductal carcinoma: luminal A, luminal B, HER2/neu, and basal-like breast cancer, based on the expression of the hormone receptors: estrogen (ER) and progesterone (PR), as well as the human epidermal growth factor (HER2)
PCAC also has additional human data besides these 5 studies the FDA publicized
This has led researchers to explore alternative delivery routes that maximize cellular uptake, stability, and systemic reach, while minimizing degradation
Although weight loss is an important consideration for a considerable proportion of type 2 diabetics, medication is not first-line therapy for weight loss, at least in part due to medication side effects (Wexler 2021a)
Introduction The therapeutic landscape for type 2 diabetes mellitus and obesity has undergone substantial transformation over the past two decades